Search for Clinical Trial Results

Sponsored By

Respiratory Syncytial Virus Infections - 27 Studies Found

Status Study
Completed Study Name: Study to Evaluate Antiviral Activity, Safety, and Pharmacokinetics of Repeated Doses of Orally Administered JNJ 53718678 Against Respiratory Syncytial Virus Infection
Condition: Respiratory Syncytial Virus Infections
Date: 2015-03-09
Interventions:
  • Drug: Placebo Participants wil
Completed Study Name: A One-Year Observation of Palivizumab in Infants at Risk for Respiratory Syncytial Virus Infection in Latin America
Condition: Respiratory Syncytial Virus Infection
Date: 2011-02-15
Completed Study Name: Prevention of RSV Infections in Bone Marrow Transplant Recipients
Condition: Respiratory Syncytial Virus Infection
Date: 1999-11-03
Interventions: Drug: RSV Polyclonal Immunoglobulin
Completed Study Name: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of a Single Intravenous Dose of MEDI-524, a Humanized Enhanced Potency Monoclonal Antibody to Respiratory Syncytial Virus (RSV), in Otherwise Healthy Children Hospitalized With RSV Infection
Condition: Respiratory Syncytial Virus Infections
Date: 2005-09-13
Interventions: Biological: MEDI-524
Completed Study Name: The Development of a Human Model of Respiratory Syncytial Virus Infection
Condition:
  • Respiratory Syncytial Virus Infections
  • Respiratory Viral Infect
    Date: 2011-05-05
    Interventions: Biological: RSV A Memphis 37 Intranasal administration
Completed Study Name: Effectiveness of Synagis (Palivizumab) Immunoprophylaxis in Preterm Infants With High Risk of Severe Respiratory Syncytial Virus (RSV) Infection
Condition: Respiratory Syncytial Virus Infection
Date: 2010-02-20
Interventions: Biological: Synagis (palivizumab), monoclonal antibody for passive immunoprophylaxis against severe RSV disease administered according to usual clinic
Terminated Study Name: A Study of AK0529 in Infants Hospitalized With RSV
Condition: Respiratory Syncytial Virus Infections
Date: 2015-05-27
Interventions: Drug: AK0529 AK0529 pellets for oral administration
Completed Study Name: A Phase 2a Study to Evaluate ALS-008176 in the Virus Challenge Model
Condition: Respiratory Syncytial Virus Infections
Date: 2014-03-20
Interventions:
  • Drug: ALS-008176
  • Drug: vehicle
Recruiting Study Name: Viral Inhibition in Children for Treatment of RSV
Condition: RESPIRATORY SYNCYTIAL VIRUS INFECTIONS
Date: 2016-01-04
Interventions:
  • Drug: AK0529 AK0529 is a novel
Completed Study Name: Surveillance Study of Respiratory Syncytial Virus Infection (RSV) in Subjects < 24 Months of Age
Condition: Respiratory Syncytial Virus Infections
Date: 2012-12-07
Next >>>